POAS
Phaos Technology Holdings (Cayman) Limited
NYSE MKT: POAS · HEALTHCARE · MEDICAL DEVICES
$2.34
+5.41% today
Updated 2026-04-30
Market cap
$29.33M
P/E ratio
—
P/S ratio
174.91x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$1 – $7
Volume
0.3M
Phaos Technology Holdings (Cayman) Limited (POAS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $650797.00 | $1.88M | $167707.00 |
| Revenue growth (YoY) | — | +189.3% | -91.1% |
| Cost of revenue | $536169.00 | $985099.00 | $130641.00 |
| Gross profit | $114628.00 | $897704.00 | $37066.00 |
| Gross margin | 17.6% | 47.7% | 22.1% |
| R&D | $26956.00 | $90566.00 | $139720.00 |
| SG&A | $1.56M | $2.08M | $3.23M |
| Operating income | $-2.04M | $-2.50M | $-5.28M |
| Operating margin | -313.8% | -132.9% | -3148.3% |
| EBITDA | $-1.45M | $-2.14M | $-4.94M |
| EBITDA margin | -222.4% | -113.6% | -2946.6% |
| EBIT | $-1.64M | $-2.32M | $-5.13M |
| Interest expense | $25066.00 | $43543.00 | $8463.00 |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-1.67M | $-2.36M | $-5.14M |
| Net income growth (YoY) | — | -41.5% | -117.7% |
| Profit margin | -256.3% | -125.3% | -3063.1% |